Bayer HealthCare LLC has received an injunction to stop a company in the United Kingdom from selling foreign Bayer Animal Health products to U.S. consumers.
The ruling is against AbbeyVet Export Ltd. The products for sale on AbbeyVet's Web sites were Advantage and K9 Advantix that Bayer had packaged for sale in the United Kingdom.
In the United States, Bayer policy specifies that Advantage and K9 Advantix are for sale only to veterinarians to ensure proper use of the products—even though they are not prescription products in this country.
"Bayer Animal Health continues to support the role of veterinarians in caring for the health of our country's companion animals," said Joerg Ohle, president and general manager of the Animal Health Division of Bayer HealthCare.
On March 24, the U.S. District Court for the Southern District of New York barred AbbeyVet from selling foreign Advantage and K9 Advantix to U.S. consumers through any channel of trade—including the company's Web sites. The court also ordered AbbeyVet to transfer ownership of the domain names advantageflea.com and advantageflea.co.uk to Bayer.